FMP
Regencell Bioscience Holdings Limited
RGC
NASDAQ
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
5.35 USD
0.35 (6.54%)
About
ceo
Mr. Yat-Gai Au
sector
Healthcare
industry
Drug Manufacturers - Specialty & Generic
website
https://www.regencellbioscience.com
exchange
NASDAQ
Description
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
CIK
0001829667
ISIN
KYG7487R1002
CUSIP
G7487R100
Address
First Commercial Building
Phone
852 2155 0823
Country
HK
Employee
12
IPO Date
Jul 16, 2021
Summary
CIK
0001829667
Exchange
NASDAQ
Industry
Drug Manufacturers -...
Sector
Healthcare
CUSIP
G7487R100
ISIN
KYG7487R1002
Country
HK
Price
5.35
Beta
-0.35
Volume Avg.
4.21k
Market Cap
69.62M
Shares
-
52-Week
3.16-30.49
DCF
0.08
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-11.89
P/B
-
Website
https://www.regencellbioscience.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest RGC News
It looks like there's no news available.
